Alx Oncology Holdings (ALXO) Prepaid Assets (2019 - 2026)
Alx Oncology Holdings (ALXO) reported Prepaid Assets of $295000.0 for Q1 2026, down 93.72% on a YoY basis from $4.7 million in Q1 2025, and down 72.4% sequentially from $1.1 million in Q4 2025.
Alx Oncology Holdings (ALXO) Prepaid Assets (2019 - 2026) Analysis & Trends
Alx Oncology Holdings (ALXO) has 8 years of Prepaid Assets data on file, last reported at $295000.0 in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets fell 93.72% year-over-year to $295000.0; the trailing twelve-month figure through Mar 2026 stood at $295000.0 (down 93.72% YoY), and the FY2025 full-year result was $1.1 million, up 3859.26% from the prior year.
- Prepaid Assets eased to $295000.0 in Q1 2026, from $1.1 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $10.4 million in Q1 2024 to a low of $27000.0 in Q4 2024.
- A 5-year average of $3.5 million and a median of $3.5 million in 2022 frame the typical range for Prepaid Assets.
- Across the five-year window, Prepaid Assets slumped 95.57% in 2024 and surged 3859.26% in 2025, its largest moves.
- Tracing ALXO's Prepaid Assets over 5 years: stood at $4.8 million in 2022, then sank by 87.21% to $609000.0 in 2023, then plunged by 95.57% to $27000.0 in 2024, then surged by 3859.26% to $1.1 million in 2025, then tumbled by 72.4% to $295000.0 in 2026.
- Business Quant data shows ALXO's Prepaid Assets at $295000.0 in Q1 2026, $1.1 million in Q4 2025, and $892000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Alx Oncology Holdings | 211.24 Mn | 211.24 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 295,000.00 |
| Dec 31, 2025 | 1.07 Mn |
| Sep 30, 2025 | 892,000.00 |
| Jun 30, 2025 | 50,000.00 |
| Mar 31, 2025 | 4.70 Mn |
| Dec 31, 2024 | 27,000.00 |
| Sep 30, 2024 | 1.23 Mn |
| Jun 30, 2024 | 315,000.00 |
| Mar 31, 2024 | 10.43 Mn |
| Dec 31, 2023 | 609,000.00 |
| Sep 30, 2023 | 9.06 Mn |
| Jun 30, 2023 | 6.73 Mn |
| Mar 31, 2023 | 4.59 Mn |
| Dec 31, 2022 | 4.76 Mn |
| Sep 30, 2022 | 5.90 Mn |
| Jun 30, 2022 | 3.48 Mn |
| Mar 31, 2022 | 4.93 Mn |
| Dec 31, 2021 | 3.35 Mn |
| Sep 30, 2021 | 3.81 Mn |
| Jun 30, 2021 | 2.31 Mn |